Odefsey - Managing HIV-1 Infection in Selected Adults

Odefsey is a prescription medication used to treat HIV-1 infection in certain adults. It is a complete regimen containing three different drugs in a single tablet.
Category
Drug
Where to get
Available with a prescription from pharmacies or healthcare providers
Applicable for
HIV-1 Infection
Prepared by Shruti Sahoo, reviewed by Dr. Eugene Smith

Odefsey FAQ


Image credit: farmalisto.com.co

What is Odefsey used for?

ODEFSEY contains the active ingredients emtricitabine, rilpivirine and tenofovir alafenamide in one tablet. ODEFSEY is used to help control Human Immunodeficiency Virus (HIV) infection. For more information, see Section 1. Why am I using ODEFSEY? in the full CMI. 2. What should I know before I use ODEFSEY?

How should I take Odefsey?

• Take ODEFSEY exactly as your healthcare provider tells you to take it. ODEFSEY is taken by itself (not with other HIV-1 medicines) to treat HIV-1 infection. • Take ODEFSEY 1 time each day with a meal. • If you are on dialysis, take your daily dose of ODEFSEY following dialysis.

Is Odefsey safe for children?

HIV-1 is the virus that causes Acquired Immune Deficiency Syndrome (AIDS). ODEFSEY contains the prescription medicines emtricitabine, rilpivirine and tenofovir alafenamide. It is not known if ODEFSEY is safe and effective in children under 12 years of age or who weigh less than 77 lb (35 kg). Who should not take ODEFSEY?

What is Odefsey made of?

Macrogol, polyvinyl alcohol, talc, titanium dioxide (E171), iron oxide black (E172). Odefsey is a grey, capsule-shaped, film-coated tablet debossed on one side with “GSI” and “255” on the other side. Odefsey comes in bottles of 30 tablets and in packs made up of 3 bottles, each containing 30 tablets.

What is Odefsey ®?

ODEFSEY® is a combination of emtricitabine, rilpivirine, and tenofovir alafenamide. See full Prescribing & Important Safety Information.

Who makes Odefsey?

Manufactured and distributed by: Gilead Sciences, Inc. Foster City, CA 94404 ODEFSEY is a trademark of Gilead Sciences, Inc., or its related companies. 2021 Gilead Sciences, Inc. All rights reserved. 208351-GS-006 For more information, call 1-800-445-3235 or go to www.ODEFSEY.com.

Odefsey References

If you want to know more about Odefsey, consider exploring links below:

What Is Odefsey

  1. https://www.odefsey.com/
  2. https://www.drugs.com/odefsey.html
  3. https://www.nps.org.au/medicine-finder/odefsey-tablets
  4. https://www.healthdirect.gov.au/medicines/brand/amt,859281000168108/odefsey
  5. https://www.gilead.com/~/media/files/pdfs/medicines/hiv/odefsey/odefsey_patient_pi.pdf?la=en
  6. https://mydr.com.au/medicines/odefsey/
  7. https://www.aidsmap.com/about-hiv/arv-factsheet/odefsey
  8. https://www.medicine.com/drug/odefsey
  9. https://patient-info.co.uk/odefsey-70587/patient-leaflet
  10. https://www.ema.europa.eu/en/medicines/human/EPAR/odefsey

Explore Related Topics

Prescribing Guidelines / Antiviral Agents for HIV

What are the key considerations for prescribing antiviral agents for HIV in elderly patients?

Discuss the specific factors that healthcare professionals should consider when prescribing antiviral agents for HIV to elderly patients, including age-related changes in metabolism.

Read 18 answer(s)
2024-Apr-09 03:07
Antiviral Medications / Antiviral Medications for HIV

What are some key considerations when switching antiviral medications for HIV treatment?

Share insights on the factors to be mindful of when transitioning between different antiviral medications during HIV treatment and potential challenges that may arise.

Read 15 answer(s)
2024-Apr-06 00:40
Antiviral Resistance / Antiviral Resistance in HIV

How can healthcare providers adapt to antiviral resistance trends in HIV?

Exchange ideas and strategies on how healthcare providers can adapt to evolving antiviral resistance trends in HIV management. Share practical tips, resources, and collaborative approaches to enhance patient care and clinical outcomes in the face of resistance challenges.

Read 15 answer(s)
2024-Mar-27 17:42